Moreover, a recent in vitro study showed that ACE2 protein expression, which is responsible for the entry of SARS-CoV-2, was increased in the lower airways in patients with COPD but decreased in those with asthma, which needs to be confirmed in further research [37]. This evidence concerns the gene ACE2 and asthma.